Down-regulation of β-1,3-N-acetylglucosaminyltransferase-8 by siRNA inhibits the growth of human gastric cancer

Molecular Medicine Reports

Volumn 4, Issue 3, 2011, Pages 497-503

  Liu, Zhenhua ^a,b   Shen, Li ^a,c   Xu, Lan ^a   Sun, Xiaoya ^b   Zhou, Jinwei ^a   Wu, Shiliang ^a  

^a SOOCHOW UNIVERSITY   (China)

^b Suzhou Health College   (China)

^c WUHAN UNIVERSITY   (China)

Author keywords

1,3 N acetylglucosaminyltransferase 8; Cancer therapy; Gastric cancer; Growth; RNAi

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; BETA 1,3 N ACETYLGLUCOSAMINYLTRANSFERASE 8; MESSENGER RNA; N ACETYLGLUCOSAMINYLTRANSFERASE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENICITY; CELL ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; DRUG TARGETING; ENZYME INHIBITION; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; MICE; MICE, NUDE; N-ACETYLGLUCOSAMINYLTRANSFERASES; RNA, MESSENGER; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION;

MUS MUSCULUS;

EID: 79953775746     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2011.448     Document Type: Article

References (22)

1. Chen T and Deng C: Inhibitory effect of siRNA targeting survivin in gastric cancer MGC-803 cells. Int Immunopharmacol 8: 1006-1011, 2008.
2. Aung PP, Oue N, Mitani Y, et al: Systematic search for gastric cancer-specifc genes based on SAGE data: melanoma inhibitory activity and matrix metalloproteinase-10 are novel prognostic factors in patients with gastric cancer. Oncogene 25: 2546-2557, 2006.
3. Huang J, Hang JT, Huang HC, et al: Beta1,4-n- acetylgalactosaminyltransferase III enhances malignant phenotypes of colon cancer cells. Mol Cancer Res 5: 543-552, 2007. (Pubitemid 46985045)
4. Petretti T, Schulze B, Schlag PM and Kemmner W: Altered mRNA expression of glycosyltransferases in human gastric carcinomas. Biochim Biophys Acta 1428: 209-218, 1999. (Pubitemid 29352268)
5. Ishikawa M, Kitayama J, Nariko H, Kolino K and Nagawa H: The expression pattern of UDP-N-acetyl-alpha-d-galactosamine: polypeptide N- acetylgalactosaminyl transferase-3 in early gastric carcinoma. J Surg Oncol 86: 28-33, 2004. (Pubitemid 38490097)
6. Inoue T, Eguchi T, Oday, et al: Expression of Ga1Nac-T3 and its relationships with clinicopathological factors in 61 extrahepatic bile duct carcinomas analyzed using stepwise sections -special reference to its association with lymph node metastases. Mod Pathol 20: 267-276, 2007. (Pubitemid 46422168)
7. Ishida H, Togayachi A, Sakai T, et al: a novel beta1,3-N- acetylglucosaminyltransferase (beta3Gn-T8), which synthesizes poly-N-acetyllactosamine, is dramatically upregulated in colon cancer. FEBS Lett 579: 71-78, 2005. (Pubitemid 40023376)
8. Huang C, Zhou J, Wu S, Shan Y, Teng S and Yu L: Cloning and tissue distribution of the human B3GaLT7 gene, a member of the beta1,3- Glycosyltransferase family. Glycoconj J 21: 267-273, 2004. (Pubitemid 39388745)
9. Seko A and Yamashita K: Activation of beta1,3-n- acetylglucosaminyltransferase-2 (beta3Gn-T2) by beta3Gn-T8. Possible involvement of beta3Gn-T8 in increasing poly-n-acetyllactosamine chains in differentiated HL-60 cells. J Biol chem 283: 33094-33100, 2008.
10. Seko A and Yamashita K: Characterization of a novel galactose beta1,3-n-acetylglucosaminyltransferase (beta3Gn-T8): the complex formation of beta3Gn-T2 and beta3Gn-T8 enhances enzymatic activity. Glycobiology 15: 943-951, 2005. (Pubitemid 41511490)
11. Young DF, Carlos TS, Hagmaier K, Fan L and Randall RE: AGS and other tissue culture cells can unknowingly be persistently infected with PIV5; a virus that blocks interferon signalling by degrading STAT1. Virology 365: 238-240, 2007. (Pubitemid 46907241)
12. Siomi H and Siomi MC: On the road to reading the rna-interference code. Nature 457: 396-404, 2009.
13. Castanotto D and Rossi JJ: The promises and pitfalls of RNA-interference-based therapeutics. Nature 457: 426-433, 2009.
14. Moazed D: Small RNAs in transcriptional gene silencing and genome defence. Nature 457: 413-420, 2009.
15. Crnkovic-Mertens I, Hoppe-Seyler F and Butz K: Induction of apoptosis in tumor cells by siRNA-mediated silencing of the livin/ML-IAP/KIAP gene. Oncogene 22: 8330-8336, 2003. (Pubitemid 37485525)
16. Evan GI and Vousden KH: Proliferation, cell cycle and apoptosis in cancer. Nature 411: 342-348, 2001. (Pubitemid 32467043)
17. Protzer CE, Preiss A and Nagel AC: Drosophila alpha- 1,4- glycosyltransferase (alpha-4GT1) inhibits reaper-mediated apoptosis in the eye. Cell Tissue Res 336: 149-158, 2009.
18. Cabrera PV, Amano M, Mitoma J, et al: Haploinsuffciency of C2GnT-I glycosyltransferase renders T lymphoma cells resistant to cell death. Blood 108: 2399-2406, 2006. (Pubitemid 44497525)
19. Hiraishi K, Suzuki K, Hakomori S and Adachi M: Le(y) antigen expression is correlated with apoptosis (programmed cell death). Glycobiology 3: 381-390, 1993.
20. Akamatsu S, Yazawa S, Zenita K, Matsumoto H, Tachikawa T and Kannagi R: Elevation of an alpha(1,3)fucosyltransferase activity correlated with apoptosis in the human colon adenocarcinoma cell line, HT-29. Glycoconj J 13: 1021-1029, 1996.
21. Brummelkamp TR, Bernards R and Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553, 2002. (Pubitemid 34408678)
22. Elbashir SM, Harborth J, Weber K and Tuschl T: analysis of gene function in somatic mammalian cells using small interfering RNAs. Methods 26: 199-213, 2002. (Pubitemid 34969582)